"Innovation"

"Capability"

"Precision"

"Trust"

From concept to
market with ease.

Djie Medical supports companies in design, developing and manufacturing products in the medical and wellness industry.
241127 wbrain render 2
Recharge 220524 transparent
240327 maxm skate render with logo transparent 2 trans
Hoya 1 trans

Who we’ve worked with

Why work with us

We’re more than a design firm. We’re your strategic partner from concept to global launch. You’ve built a trusted brand through years of clinical excellence, education, and patient results. Now you’re ready to create a product that fully reflects your expertise—and stands apart from generic, white-label solutions. That’s where we come in.

Paceblade 2
20231129 185012
20231031 160926
Img 2379

Our Expertise

With our extensive experience in the field, we can support you through every stage of bringing your product to market.

  • 01

    User-centric from the start

    For us, the user is always at the center.

    From day one, we align user needs, regulatory standards, and risk management with integrated expertise in design, technology, distribution, and compliance — ensuring safe, high-quality outcomes.

  • 02

    Iterate to exceed

    Prototyping drives progress.

    Iterative testing fuels rapid improvement, enabling outcomes that meet or exceed expectations.

    Fail fast. Learn faster.

  • 03

    Distributor engagement built-in

    Early activation for global readiness.

    Our distributor program starts early — aligning on regulatory requirements, gaining market insights, and ensuring launch readiness. This enables smoother rollout, stronger adoption, and full compliance.

    We treat all stakeholders as users — and aim for quality outcomes for every one of them.

  • 04

    Service built to last

    Support that evolves with you.

    We pair high-quality, secure manufacturing with responsive, user-centered service and long-term support.

    Our partnerships span decades, driving ongoing improvement through user feedback — all anchored in top industry standards.

We don’t work with everyone—and that’s intentional.

Are we a match?

Our service is designed for partners who value long-term collaboration, strategic innovation, and products that make a real difference in people’s lives. If you’re seeking more than just a supplier—if you want a trusted partner who thinks with you, challenges your assumptions, and brings transformative ideas to the table—we may be the right fit.

We’re a great fit if you...

The companies that thrive with us usually share a few things in common.

  • Have a strong brand & credible results

    We work best with companies that already know their market deeply and have earned the trust of professionals and patients alike.
  • Are prepared to fund your development

    Most of our projects are client-funded. In select cases, we may co-invest or support fundraising when there’s platform-level potential.
  • Want to focus on what you do best

    We complement our partners by taking over R&D, design, development, and manufacturing—so they can focus on medical excellence, education, marketing, and sales.
  • Understand long-term partnerships

    We thrive in relationships built on trust, clear communication, and professionalism under pressure. We walk away from short-term or untrustworthy behavior.
  • Value strategic thinking beyond the brief

    We often propose new product concepts or business models based on emerging technologies or untapped market opportunities. We’re proactive collaborators, not passive executors.
  • Respect confidentiality and IP clarity

    Typically, intellectual property is assigned to the client. For co-investments, we align early on equity, licensing, or shared IP ownership.
Pxl 20240904 024954575

We are a senior, highly focused team that works hands-on with every client we engage.

  • Founded by an award-winning designer with a medical background, our core team brings together world-class engineering, global distribution expertise, and cutting-edge UX/UI design.

  • We don’t hand off work to juniors or interns—ever. Every project receives the full attention of our most experienced people, from start to finish.

  • In close partnership with a dedicated team of 25 engineers and exclusive manufacturing partners, we operate from Taipei and Chiang Mai, with a presence in Amsterdam and Austin. Our tight-knit structure allows us to move fast, think deeply, and build products that truly matter.

Adam Smith
CEO, Company

“Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.”

Adam John
CEO, Company

“Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.”

Let's talk

If you're looking for a team that brings clinical depth, award-winning design, deep tech capability, and decades of global execution—let’s start a conversation.

Email

Contact us via email.

eric@djiemedical.com

Esc

Ar3i0283

Endolight: Advancing Photodynamic Therapy from Concept to Reality

Project Overview

A Vision for Internal Light-Based Therapy

The Weber Medical Endolight was born from a bold idea: to bring the power of light-based therapy deep into the bodynon-invasively and with clinical precision. Working in close collaboration with Weber Medical, Eric Djie and the team at Djie Medical translated this vision into a reliable and effective endoluminal phototherapy device.

The result is a light-delivery system designed for targeted internal application of photodynamic therapy (PDT) and low-level laser therapy (LLLT). The Endolight enables physicians to reach deep tissues via flexible optical fibers, illuminating treatment sites with controlled wavelengths inside the body for cancer treatment, inflammation modulation, and immune system support.

Our Role: From Concept to Manufacturing

Djie Medical played an end-to-end role in the Endolights development:

  • Feasibility Engineering: Early validation of fiber optics, light dispersion, and medical safety
    requirements
  • Mechanical and Industrial Design: Ergonomic, compact form factor suitable for both clinics and
    hospital environments
  • Electrical and Firmware Development: Safe and stable control over multiple wavelengths and
    output levels
  • Prototype Iteration and Testing: Close collaboration with medical users to refine usability and
    therapeutic effectiveness
  • ISO13485-Compliant Manufacturing: Scalable production with full documentation and traceability

This hands-on development cycle ensured the Endolight was not just technically functional but also medically practical and regulatory-ready.

Built on Medical Insight

Eric Djies medical training (Bachelor of Medicine, VUB Brussels) and years of experience in medical product innovation were instrumental in shaping the device:

  • Understanding clinical applications like photodynamic tumor treatment and chronic inflammation
  • Interpreting clinical research to guide wavelength selection, energy parameters, and usability
    features
  • Engaging with physicians on a professional level to gather feedback and translate it into product
    features

This ability to engage with healthcare professionals as both an engineer and medical peer gave the Endolight a unique advantage in both design and acceptance.

Impact and Clinical Use

The Endolight is now a key component of Weber Medical’s global photodynamic therapy portfolio, used in more than 30 countries by clinics focused on:

  • Oncology (e.g. PDT with indocyanine green or curcumin)
  • Chronic inflammatory conditions
  • Lyme disease and stealth pathogen protocols
  • Mitochondrial and regenerative therapy

Its compact, flexible light delivery system has expanded the frontiers of non-invasive and systemic phototherapy, offering a high level of control and integration with Weber’s other devices.

From Collaboration to Capability

This case illustrates how Djie Medical transforms complex therapeutic concepts into fully functional medical devices backed by science, designed with care, and built to scale.

The Endolight reflects our commitment to:

  • Merging medical insight with precision engineering
  • Supporting clinicians with powerful, intuitive tools
  • Delivering high-value devices to global health innovators
Recharge 220524 transparent
Web 8 copy
Ar3i3459
Ar3i0283
Ar3i0204
Ar3i3447
Ar3i3464
Ar3i3597

Esc

Paceblade 2

PaceBlade: Human-Centered Computing for Extreme Environments

Project Overview

Origins and Vision

PaceBlade Technology was founded by Eric Djie, a medical professional turned product innovation leader, with a vision to revolutionize how computing devices support human performance in demanding environments. Long before tablets became ubiquitous, PaceBlade pioneered ruggedized mobile platforms that could survive and perform in industrial, military, and space settings.

At the center of this vision was the PaceBookone of the worlds first modular tablet PCs. Designed to meet the needs of field professionals, it integrated touchscreen computing, wireless connectivity, GPS, and biometric data capabilities into a single, durable device.

With headquarters in Taiwan and operations in California, Germany, and Japan, the company served global OEM partners and agencies needing reliability at the edgewhere failure is not an option.

Awards and Recognition

PaceBlades work received early and sustained recognition for its innovation and design quality:

  • Finalist for Best of Comdex
  • Nominated for the Red Dot Design Award
  • Honored in multiple industrial innovation showcases across Asia and Europe

NASA and the International Space Station

One of PaceBlade’s most impactful contributions was the integration of the PaceBook tablet PC into NASA’s COLBERT treadmill system aboard the International Space Station.

More than a UI tool, the PaceBook served as a biometric data collection and monitoring interface. It gathered live physiological data from astronautsincluding:

  • Heart rate
  • Exercise compliance metrics
  • Biomechanical feedback

This made the PaceBook a vital component in managing astronaut health in microgravity, contributing to NASAs long-term understanding of endurance physiology and adaptation in space.

PACEBLADE at the NASA International Space Station 2009 – 2014

The Role of Medical Training

Eric Djies Bachelors degree in Medicine (VUB Brussels) provided a strong foundation for engaging with medical and physiological disciplines throughout his technology career. This background enabled him to:

  • Understand and apply medical and scientific literature during product development
  • Collaborate credibly with clinical, physiological, and research professionals
  • Contribute meaningfully to product concepts and technical directions involving biometric monitoring and human performance

This unique perspective helped PaceBlade develop solutions that were not just technically sound but physiologically meaningfulbridging the gap between field hardware and human health.

Legacy and Relevance to Djie Medical

The PaceBlade journey laid a deep foundation for what we now do at Djie Medical: combining medical science, technology, and design to improve human health and performance.

Where PaceBlade brought rugged intelligence into extreme environments, Djie Medical brings therapeutic precision and sensor-enabled insight into everyday wellness and clinical contexts. Both share the same DNA: build meaningful tools for the body, mind, and mission.

This is one in a series of case studies that reflect our founders journey and the values that shape our work with every client.

2. paceblade 2
4. paceblade 3

Esc

Interx 2

InterX: Neurostimulation Technology for Pain and Recovery

Project Overview

Innovation at the Intersection of Neuroscience and Technology

The InterX device is a breakthrough in interactive neurostimulation, developed by British physiologist and innovator Guy Beckerlegge. Designed to treat acute and chronic pain non-invasively, InterX leverages proprietary algorithms and adaptive electrical impulses to stimulate the skin and underlying nerves, promoting both localized and systemic therapeutic effects.

Unlike traditional TENS units, InterX adjusts in real-time based on skin impedance and physiological feedback. This dynamic interaction enables personalized, responsive treatment, improving outcomes in pain reduction, muscle recovery, and mobility restoration.

Therapeutic Applications

InterX is widely used in:

  • Post-operative pain management (orthopedic and soft tissue)
  • Sports injuries and rehabilitation programs
  • Neuropathic pain, including nerve impingement and radiculopathy
  • Chronic inflammatory conditions, such as fibromyalgia and arthritis

By targeting peripheral nerves and modulating central pain pathways, InterX provides a non-pharmaceutical alternative that aligns with both modern rehabilitation and integrative medicine models.

Technology Principles

  • Adaptive Stimulation: The device continuously monitors skin impedance and adjusts stimulation levels accordingly.
  • Non-invasive Interface: No needles, gels, or invasive procedures are needed; treatment is administered via handheld electrodes.
  • Neuro-modulatory Effect: Stimulates C-fibers and A-delta fibers to initiate systemic neuroimmune responses and local pain modulation.

Clinical Validation and Impact

The InterX has been studied and used in leading sports medicine programs, elite athletic recovery centers, and military rehabilitation protocols. Notably, it was adopted during:

  • Olympic training cycles
  • British military pain clinics
  • U.S. Department of Defense pilot programs

Its effectiveness has been supported in peer-reviewed studies showing significant improvement in pain scores and functional outcomes when compared to traditional modalities.

Relevance to Djie Medical

At Djie Medical, we share the vision that intelligent, bio-interactive technologies will define the next generation of therapeutic tools. The InterX case illustrates:

  • The power of real-time feedback in therapeutic technology
  • How neuromodulation can serve both acute and chronic patient needs
  • The importance of user-centered design in device adoption

As we continue to innovate in areas like biophotonics, low-level laser therapy, and sensor-based therapeutics, InterX stands as a compelling example of how engineering, physiology, and clinical insight converge to change lives.

Interx 1a
Interx 5
Dome400 0078 600x564 300x300 copy
Reserve interx 3

Esc

Weberbrain card header

WeberBrain: Revolutionizing Transcranial Light Therapy

Project Overview

Redefining Brain Health through Precision Photobiomodulation

Project Overview

In 2015, Weber Medical pioneered the use of red and near-infrared LED light therapy for brain health with the development of the Weber Infrared LED Helmet. The system showed promising outcomes in clinical applications for Alzheimer’s disease, Parkinson’s, ADHD, and PTSD. Backed by growing scientific validation, light therapy is increasingly recognized as an effective adjunct treatment for neurological and psychiatric disorders.

However, as adoption expanded, so did the need for a next-generation system—one that combined cutting-edge light delivery, enhanced user experience, and evidence-based clinical insight.

The Challenge

Weber Medical, drawing from years of user feedback and clinical application, identified critical areas for improvement:

  • Optimization of light penetration for targeted brain regions
  • Flexible usability for both clinics and home users
  • Improved ergonomics and patient comfort
  • Seamless digital interface for protocol customization and monitoring
  • Compliance with modern safety and performance standards

This sparked the beginning of an ambitious collaboration.

The Collaboration

In late 2022, Weber Medical partnered with Djie Medical to completely reimagine what transcranial photobiomodulation could be.
Together, we set out to:

  • Re-engineer every hardware and software component from the ground up
  • Integrate decades of medical experience with innovative engineering and design
  • Create a scalable, globally viable solution

The Process

Over a period of 2.5 years, a dedicated team of over 15 specialists from Djie Medical worked hand-in-hand with the Weber Medical research and clinical team. Our cross-functional development included:

  • Industrial Design & Ergonomics – a reengineered helmet form that fits comfortably and securely while maximizing contact with target regions
  • Optical & Electrical Engineering – integration of state-of-the-art red and NIR light sources with precise output control and safety redundancy
  • Firmware & Software Development – an intuitive user interface for clinicians and end-users, complete with protocol selection, tracking, and updates
  • UX/UI – user testing across demographics to ensure accessibility, clarity, and satisfaction
  • Medical & Scientific Validation – co-developed with neuroscientists and photobiomodulation experts to ensure alignment with the latest clinical findings

The Outcome: WeberBrain

Launching in Summer 2025, the WeberBrain represents the most advanced system for transcranial light therapy on the market today.

Key Innovations:

  • Targeted wavelength control for individualized treatment protocols
  • Clinician and home-user modes, simplifying deployment across care settings
  • Wireless operation and app-based interface for flexible monitoring and remote updates
  • Upgradable firmware ensuring future-ready performance
  • Modular design for ease of cleaning, servicing, and scaling

Global Impact & Future Outlook

Djie Medical not only led the product development but also supported Weber Medical in setting up a global distributor network, ensuring access to WeberBrain for clinicians and patients worldwide.

As the field of photobiomodulation evolves, the WeberBrain is positioned to become the gold standard in non-invasive neurological support—bridging scientific discovery with real-world healing.

Weberbrain guy
241127 wbrain render 4
250325 helmet pro dark.10 min
241127 wbrain render 1 min
241127 wbrain render 2

Esc

Huijia header

Huijia nFOPT: Unobtrusive Vital Signs Sensor and Digital Biomarkers

Project Overview

Overview

Since 2022, Djie Medical has collaborated with Huijia Health Care in Taiwan to bring the Huijia nFOPT (Non-invasive Fiber Optic Physiological Monitoring Technology) system to the global healthcare market. This cutting-edge technology represents a breakthrough in non-contact vital signs monitoring, particularly for the diagnosis and long-term management of Sleep Apnea, a condition affecting an ever-growing segment of the global population.

Unlike conventional sleep diagnostics that rely on cumbersome equipment, the nFOPT system is completely unobtrusive—no wires, no wearables—yet it delivers data quality comparable to the gold standard Type 2 Polysomnography (PSG).

Clinical Significance: A New Era for Sleep Apnea Diagnosis

Sleep Apnea is linked to cardiovascular disease, cognitive impairment, and metabolic disorders. Traditional diagnostic pathways are resource-intensive and often uncomfortable for patients.

The nFOPT system changes this paradigm by offering:

  • High fidelity data capture of respiration, heart rate, movement, and micro-vibrations
  • 100x signal resolution over existing contactless solutions
  • Compatibility with home use and clinical environments, encouraging more frequent and earlier screening

The system’s passive and non-invasive nature dramatically increases patient compliance and opens the door to continuous, long-term monitoring in ways previously unattainable.

Strategic Collaboration: Combining Innovation with Market Expertise

To scale this innovation globally, Djie Medical:

  • Assembled a world-class commercialization team, including a former executive from one of the world’s leading Sleep Apnea solution providers
  • Established a Singapore-based joint venture with Huijia Health Care called the Digital Biomarker Company. This venture enables flexible global deployment, IP protection, and regulatory alignment
  • The Digital Biomarker Company is currently in the process of fundraising, with several highly promising investors expressing strong interest in being part of this exciting venture
  • Initiated early-stage collaborations with sleep clinics and digital health partners across Asia, Europe, and North America

Digital Biomarkers: Unlocking the Future of Precision Medicine

The extraordinary resolution of the nFOPT system makes it an ideal platform for digital biomarker development—a key enabler of predictive and preventative healthcare.
The richness and granularity of the signal enable:

  • Detection of subtle physiological changes well before clinical symptoms emerge
  • AI-driven insights into sleep quality, cardiovascular trends, stress levels, and other longitudinal health metrics
  • A foundation for building personalized therapeutic pathways and predictive diagnostics

Looking Ahead

This positions the nFOPT system at the forefront of next-generation digital medicine, where software-enhanced sensing unlocks transformative insights from invisible patterns in human physiology.

Djie Medical and Huijia Health Care continue to evolve the nFOPT ecosystem, including:

  • Integration with cloud-based health platforms
  • Clinical trials with leading hospitals and research institutions
  • Expansion into elderly care, chronic disease management, and remote patient monitoring

With the nFOPT platform, Djie Medical is not just advancing Sleep Apnea care—it’s laying the groundwork for a new model of passive, intelligent, and highly personalized healthcare.

Esc

Maxm header

MAXM: Transforming Knee Replacement Recovery Through Sensor-Driven Motion Therapy

Overview

In 2023, Djie Medical partnered with MAXM to transform a bold clinical concept into a commercial medical device that redefines post-operative knee replacement therapy. Spearheaded by orthopedic surgeon Dr. Liptak and supported by Flinders University’s Medical Device Research Institute (MDRI), the MAXM Skate integrates real-time motion data capture with a physical rehabilitation device—ushering in a new era of personalized recovery, patient motivation, and systemic cost savings.

Challenge

Patients recovering from total knee replacement surgery often experience limited mobility, pain, and low motivation to adhere to physiotherapy regimens. Traditional therapy lacks real-time feedback, resulting in inconsistent adherence and outcomes. The challenge: Could a wearable sensor embedded in a skate-like device provide measurable, motivating, and clinically effective support during recovery?

Solution

Dr. Liptak’s concept envisioned a low-friction exercise skate with integrated motion sensing. Collaborating with MDRI engineers and Djie Medical, the MAXM Skate evolved from a prototype into a globally patented solution:

  • Sensor Innovation: The first MAXM motion sensor prototype demonstrated that capturing and transmitting real-time range of motion (ROM) data from a moving skate was technically viable. MDRI subsequently developed two new wireless sensors that integrate with a smartphone app, enabling remote progress tracking by patients and clinicians.
  • Biomechanical Excellence: The unique curvature of the MAXM Skate was refined through iterative prototyping and user testing. This patented geometry optimizes comfort and biomechanical efficiency during recovery exercises.
  • Digital Engagement: A companion smartphone app offers live progress tracking, goal setting, and remote clinician feedback—boosting patient motivation and adherence.
  • Product Redesign by Djie Medical: Djie Medical led a full redesign of the MAXM Skate Version 2.0, delivering improvements in aesthetics, usability, and production efficiency to enable global scale-up.

Impact

Clinical trials demonstrated substantial benefits:

  • Faster Recovery: Patients using MAXM recovered ROM more quickly and with less pain.
  • Improved Compliance: Real-time app feedback increased patient engagement and adherence.
  • Systemic Cost Savings: Health systems reported savings of $8,000–$25,000 per patient, driven by reduced hospital stays, complications, and follow-up interventions.

Commercialization & Global Reach

  • June 2024: MAXM Skate Version 1.0 entered production in Australia. A commercial team was formed following successful capital raises.
  • 2024–2025: Djie Medical collaborated with MAXM to redesign the skate and support global market readiness.
  • Distributor Network Setup: Djie Medical established a global distributor network, identifying and onboarding local partners to ensure support and market penetration.
  • MAXM Skate 2.0 Launched: Orders fulfilled in India, Mexico, Dubai, USA, UK, Taiwan, and Australia, expanding global access to next-generation rehabilitation technology.

Timeline Snapshot

MilestoneDate
Concept DevelopmentAugust 2023
Sensor Prototype ValidatedOctober 2023
Clinical Trials CompletedEarly 2024
Version 1.0 Manufacturing BeginsJune 2024
Global Distributor Network EstablishedLate 2024
MAXM 2.0 Global Orders FulfilledEarly 2025

Partners

  • MAXM Medical
  • Djie Medical
  • Flinders University MDRI
  • Global Distribution Partners

Conclusion

The MAXM Skate sets a new benchmark for modern, sensor-enabled rehabilitation. By merging clinical insight, biomechanical design, and digital feedback, MAXM empowers patients to take charge of their recovery while helping health systems lower costs and improve outcomes. Djie Medical played a critical role in engineering, redesign, and global commercialization, enabling MAXM’s transformation from concept to international scale.

240327 maxm skate render with logo transparent 2 trans
240327 maxm skate render with logo transparent min